Business
BioSpectrum Asia
Singapore launches national Familial Hypercholesterolaemia genetic testing programme
The Ministry of Health (MOH), Singapore government, has launched the national Familial Hypercholesterolaemia (FH) genetic testing programme on June 30, 2025, as part of its broader strategy to enhance preventive care in Singapore.
1 min |
BioSpectrum Asia July 2025
BioSpectrum Asia
PacBio expands distribution in China gaining access to new clinical lab networks
PacBio, a leading provider of high-quality, highly accurate sequencing solutions, has announced the appointment of Haorui Gene, a globally recognised leader in blood typing genomics, as an official distributor in China.
1 min |
BioSpectrum Asia July 2025
BioSpectrum Asia
Taiwan's biotech gathers momentum
Leader: Backed by coordinated efforts from both government and industry, Taiwan's biotechnology sector is expanding steadily, with revenues reaching approximately $23.3 billion in 2023. The industry is positioning itself as an important player in the global biotech value chain. But what will it take for Taiwan to grow into a $32 billion biotech economy? Let's find out.
7 min |
BioSpectrum Asia July 2025
BioSpectrum Asia
GHIT Fund invests $4.5 M to develop diagnostics for TB
Japan-based Global Health Innovative Technology (GHIT) Fund has announced an investment of approximately JPY 679 million ($4.5 million) for the development of diagnostics for tuberculosis (TB); in addition to an investment of approximately JPY 15.9 million ($0.1 million) for a drug discovery project for Chagas disease and leishmaniasis (by Kitasato University, Nagasaki University, University of Tokyo, and Drugs for Neglected Diseases initiative (DNDi).
1 min |
BioSpectrum Asia June 2025
BioSpectrum Asia
Beyond the Algorithm: Why MedComms Still Need Human Pulse
In an industry, now shaped by artificial intelligence (AI)-driven efficiencies and machine-generated drafts, it's natural to wonder: Is the medical communicator (MedComm) becoming obsolete?
5 min |
BioSpectrum Asia June 2025
BioSpectrum Asia
WHO and Medicines Patent Pool announce sublicensing agreement for RDT technology
The World Health Organization (WHO) and Medicines Patent Pool (MPP) have announced a sublicensing agreement between MPP and a Nigerian health technology company, Codix Bio, to start development and manufacturing of rapid diagnostic tests (RDTs) using technology transferred from global in-vitro diagnostics company – SD Biosensor.
1 min |
BioSpectrum Asia June 2025
BioSpectrum Asia
Oliver Healthcare Packaging opens manufacturing facility in Malaysia
Oliver Healthcare Packaging, a leading healthcare company driving quality and innovation in medical packaging, has opened its new 120,000 square foot manufacturing facility in Johor, Malaysia.
1 min |
BioSpectrum Asia June 2025
BioSpectrum Asia
UK to roll out Avoiding Brain Injury in Childbirth programme
Expectant mothers will receive safer maternity care as a new National Health Service (NHS) programme to help prevent brain injury during childbirth is rolled out across the country.
1 min |
BioSpectrum Asia June 2025
BioSpectrum Asia
Nursing workforce grows, inequities threaten global health goals: WHO
The global nursing workforce has grown from 27.9 million in 2018 to 29.8 million in 2023, but wide disparities in the availability of nurses remain across regions and countries, according to the State of the World’s Nursing 2025 report, published by the World Health Organization (WHO), International Council of Nurses (ICN) and partners.
1 min |
BioSpectrum Asia June 2025
BioSpectrum Asia
ekincare raises strategic investment from MSD IDEA Studio Asia Pacific
ekincare, India’s leading artificial intelligence (AI)-powered integrated digital health gateway, has announced the raising of a strategic, undisclosed investment led by global healthcare leader MSD (tradename of Merck & Co., Inc., Rahway, N.J., USA) through MSD IDEA Studio Asia Pacific, an initiative by the MSD Global Health Innovation Fund (MGHIF).
1 min |
BioSpectrum Asia June 2025
BioSpectrum Asia
Lotus Pharma inks $125 M deal with LENZ Therapeutics to commercialise presbyopia treatment
US-based LENZ Therapeutics, Inc. and Taiwan's Lotus Pharmaceutical have announced an exclusive license and commercialisation agreement for Lotus to commercialise LNZ100 for the treatment of presbyopia in the Republic of Korea and certain countries in Southeast Asia.
1 min |
BioSpectrum Asia June 2025
BioSpectrum Asia
Emerging GCC Hotspots in APAC: Spotlight on Singapore, Malaysia, and the Philippines
The Asia-Pacific (APAC) region is now a top choice for Life Sciences and Healthcare (LSHC) multinationals to establish their Global Capability Centres (GCCs). India leads with over 100 GCCs, while countries like Singapore, Malaysia, and the Philippines offer cost-effective advantages.
5 min |
BioSpectrum Asia June 2025
BioSpectrum Asia
Korea steps up support for expanding traditional medicine overseas
The Ministry of Health and Welfare (MoHW), government of South Korea and the National Institute for Korean Medicine Development (NIKOM) have selected seven new medical institutions for the Traditional Korean Medicine Overseas Expansion Support Programme, with three for overseas expansion and four for attracting Chinese patients.
1 min |
BioSpectrum Asia June 2025
BioSpectrum Asia
HKBU and Shanghai Industrial Investment to advance medical education and research
Hong Kong Baptist University (HKBU) and Shanghai Industrial Investment (Holdings) Co Ltd (SIIC) have announced a strategic partnership aimed at leveraging their respective strengths to advance the proposed establishment of Hong Kong's third medical school, contributing to Hong Kong's development into an international hub for medical training, research, and innovation.
1 min |
BioSpectrum Asia June 2025
BioSpectrum Asia
Singapore approves Dupixent as first-ever biologic medicine for COPD
The Health Sciences Authority (HSA) in Singapore has approved Dupixent (dupilumab) for adults as an add-on maintenance treatment for uncontrolled chronic obstructive pulmonary disease (COPD) characterised by raised blood eosinophils who are on a stable combination of an inhaled corticosteroid (ICS), a long-acting beta2-agonist (LABA), and a long-acting muscarinic antagonist (LAMA), or on a combination of a LABA and a LAMA if ICS is not appropriate.
1 min |
BioSpectrum Asia June 2025
BioSpectrum Asia
Australia starts world- first immunotherapy trial to treat Type 1 diabetes
Researchers at The University of Queensland (UQ), Australia have dosed 5 participants in the first clinical trial of a potentially revolutionary immunotherapy drug to treat Type 1 diabetes.
1 min |
BioSpectrum Asia June 2025
BioSpectrum Asia
Syncell unveils new partner network expanding commercial capabilities in Taiwan
Taiwan-based Syncell, a leader in next-generation subcellular protein purification and spatial proteomics analysis, has announced the launch of their preferred partner network.
1 min |
BioSpectrum Asia June 2025
BioSpectrum Asia
SK bioscience joins Korea's national initiative to develop Avian Influenza Vaccine
SK bioscience has been selected for the Korea Disease Control and Prevention Agency (KDCA)'s Priority Infectious Disease Pandemic Preparedness Rapid R&D Support Programme.
1 min |
BioSpectrum Asia June 2025
BioSpectrum Asia
Korea develops retinal therapy to restore lost vision
Researchers at Korea Advanced Institute of Science and Technology (KAIST) have successfully developed a novel drug to restore vision.
1 min |
BioSpectrum Asia June 2025
BioSpectrum Asia
Intco Medical launches Syntex synthetic disposable latex gloves in China
Intco Medical, based in China, has announced the global launch of its exclusive patented Syntex Synthetic Disposable Latex Gloves product.
1 min |
BioSpectrum Asia June 2025
BioSpectrum Asia
Africa CDC and Unitaid partner to strengthen equitable access to health products in Africa
The Africa Centres for Disease Control and Prevention (Africa CDC) and Unitaid have formed a new strategic partnership to expand the production of essential health products in Africa and improve sustainable access to medicines, diagnostics, and medical oxygen across the continent.
1 min |
BioSpectrum Asia June 2025
BioSpectrum Asia
Bora Pharma appoints industry veteran JB Agnus as Chief Commercial Officer
Taiwan-based Bora Pharmaceuticals, a global leader in pharmaceutical manufacturing, has announced the appointment of Jean-Baptiste (JB) Agnus as Chief Commercial Officer.
1 min |
BioSpectrum Asia June 2025
BioSpectrum Asia
WHO warns of slowing global health gains
The World Health Organization (WHO) has published its World health statistics report 2025, revealing the deeper health impacts caused by the COVID-19 pandemic on loss of lives, longevity and overall health and well-being.
1 min |
BioSpectrum Asia June 2025
BioSpectrum Asia
Lotte Biologics invests $100 M in new ADC manufacturing facility in US
South Korea-based Lotte Biologics has signed a manufacturing agreement with an Asia-based biotech company for the production of a clinical-stage antibody drug conjugate (ADC) candidate.
1 min |
BioSpectrum Asia June 2025
BioSpectrum Asia
"Vaccine firms and governments remain focused on more traditional vaccine platforms in the near term"
The COVID-19 pandemic helped usher in a new era of vaccines and expanded the roster of modalities that can be applied to address some of the world's most infectious diseases.
2 min |
BioSpectrum Asia June 2025
BioSpectrum Asia
Agilent partners with Ubix Therapeutics to advance transformative cancer research in South Korea
Agilent Technologies Inc. has signed a Memorandum of Understanding (MoU) with Ubix Therapeutics to accelerate highly targeted cancer therapy research and development in South Korea over the next five years.
1 min |
BioSpectrum Asia June 2025
BioSpectrum Asia
APAC'S ALLIANCE-DRIVEN BIOTECH BOOM
Partnerships are a cornerstone of the biotech innovation process. COVID-19 acted as a catalyst, accelerating collaboration across the sector and prompting partnerships between established players for the first time.
8 min |
BioSpectrum Asia June 2025
BioSpectrum Asia
Addressing Women's Health with Portable Devices
The confluence of innovation, affordability, and accessibility creates a compelling market proposition for healthcare providers, diagnostic chains, corporate wellness programmes, and public health systems alike in cancer care with focus on women's cancer in Asia.
5 min |
BioSpectrum Asia June 2025
BioSpectrum Asia
TPG acquires 35% stake in Schott Poonawalla from Serum Institute of India
Schott Pharma, a pioneer in drug containment and delivery solutions, has announced that TPG, a leading global alternative asset management firm, has entered into a binding agreement to acquire a 35 per cent stake in its joint venture Schott Poonawalla from Serum Institute of India (SII).
1 min |
BioSpectrum Asia June 2025
BioSpectrum Asia
Sim Foundation pledges S$15 M to NTU Singapore to leverage AI in medical education & research
The Sim Foundation has pledged a gift of S$15 million to Nanyang Technological University, Singapore (NTU, Singapore), which will bolster the University’s efforts in delivering transformative healthcare through education and research.
1 min |